Revenue breakdown: Service (25.5%), Product (24.5%), Appliances (20.3%).
8-K
Vivos Therapeutics, Inc. entered into a private placement agreement with V-Co Investors 3 LLC on March 31, 2026, raising $850,000 in cash plus $1,400,000 in converted bridge financing, issuing common stock and warrants with anti-dilution protections and resale registration obligations.